Catharina Van Elssen

Expression of aberrantly glycosylated Mucin‐1 in ovarian cancer

Catharina Van Elssen, Peter Frings, Freek Bot et al. · Histopathology · 2010 · 76 citations · Full text

Medicine, Oncology, Pathology +17

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

Bob Löwenberg, Thomas Pabst, Johan Maertens et al. · Blood Advances · 2021 · 66 citations · Full text

Medicine, Oncology, Pharmacology +16

Inflammation restraining effects of prostaglandin E2 on natural killer–dendritic cell (NK-DC) interaction are imprinted during DC maturation

Catharina Van Elssen, Joris Vanderlocht, Tammy Oth et al. · Blood · 2011 · 62 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease

Catharina Van Elssen, Mohammad Rashidian, Vladimir Vrbanac et al. · Journal of Nuclear Medicine · 2017 · 57 citations · Full text

Life Sciences, Immunology, Pathology +16

<i>Klebsiella pneumoniae</i>‐triggered DC recruit human NK cells in a CCR5‐dependent manner leading to increased CCL19‐responsiveness and activation of NK cells

Catharina Van Elssen, Joris Vanderlocht, Peter Frings et al. · European Journal of Immunology · 2010 · 39 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17